scholarly article | Q13442814 |
P356 | DOI | 10.1016/0014-2999(84)90333-9 |
P698 | PubMed publication ID | 6479216 |
P2093 | author name string | Shannon M | |
Glennon RA | |||
Battaglia G | |||
Titeler M | |||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 23-29 | |
P577 | publication date | 1984-06-01 | |
P1433 | published in | European Journal of Pharmacology | Q1376712 |
P1476 | title | 5-HT1 and 5-HT2 binding properties of derivatives of the hallucinogen 1-(2,5-dimethoxyphenyl)-2-aminopropane (2,5-DMA). | |
P478 | volume | 102 |
Q34167104 | 1-(2,5-Dimethoxy-4-iodophenyl)-2-aminopropane (DOI) exerts an anorexic action that is blocked by 5-HT2 antagonists in rats |
Q35888271 | 5-HT1A agonists increase and 5-HT3 agonists decrease acetylcholine efflux from the cerebral cortex of freely-moving guinea-pigs |
Q48728233 | 5-HT2A receptor-mediated regulation of brain-derived neurotrophic factor mRNA in the hippocampus and the neocortex. |
Q34185697 | 5-hydroxytryptamine(2A) receptors regulate sympathetic nerves constricting the cutaneous vascular bed in rabbits and rats |
Q35851456 | A review and reevaluation of the role of serotonin in the modulation of lordosis behavior in the female rat |
Q42563347 | Behavioural evidence for a functional interaction between central 5-HT2 and 5-HT1A receptors |
Q34192427 | Brain structures and neurotransmitters regulating aggression in cats: implications for human aggression |
Q35942133 | Centrally active 5-HT receptor agonists and antagonists |
Q48362746 | Characteristics of agonist displacement of [3H]ketanserin binding to platelet 5-HT2A receptors: implications for psychiatric research |
Q48787534 | Depletion of brain serotonin differently affects behaviors induced by 5HT1A, 5HT1C, and 5HT2 receptor activation in rats |
Q43633225 | Different role of 5-HT1A and 5-HT2 receptors in spinal cord in the control of nociceptive responsiveness |
Q35803439 | Effects of hallucinogenic agents mescaline and phencyclidine on zebrafish behavior and physiology. |
Q33899072 | Effects of selected serotonin 5-HT(1) and 5-HT(2) receptor agonists on feeding behavior: possible mechanisms of action |
Q52165520 | Effects of serotonin 5-HT(1) and 5-HT(2) receptor agonists in a conditioned taste aversion paradigm in the rat. |
Q44574538 | Effects of serotonin 5-HT(1/2) receptor agonists in a limited-access operant food intake paradigm in the rat. |
Q73314507 | Effects of serotonin(1/2) receptor agonists on dark-phase food and water intake in rats |
Q42707728 | Evidence that activation of 5-HT2 receptors in the forebrain of anaesthetized cats causes sympathoexcitation |
Q59478852 | First Intramolecular Alkylation of Nitriles with Primary and Secondary Alcohols Catalyzed by Iridium Complexes |
Q41265940 | Functional role of 5-HT2 receptors in the regulation of sleep and wakefulness in the rat. |
Q34041519 | Hallucinogenic drug interactions at human brain 5-HT2 receptors: implications for treating LSD-induced hallucinogenesis |
Q24595389 | Head-twitch response in rodents induced by the hallucinogen 2,5-dimethoxy-4-iodoamphetamine: a comprehensive history, a re-evaluation of mechanisms, and its utility as a model |
Q43503640 | Hyper-responsiveness to 5-HT2Agonists by Tumour-linked Arterioles in Mice: Consequences for Tumour Growth |
Q48488302 | Inhibition of histamine turnover by 8-OH-DPAT, buspirone and 5-hydroxytryptophan in the mouse and rat brain |
Q40457646 | Interactions between 5-hydroxytryptamine receptor subtypes: Is a disturbed receptor balance contributing to the symptomatology of depression in humans? |
Q41387206 | Mescaline: excitatory effects on acoustic startle are blocked by serotonin2 antagonists |
Q34427738 | Pharmacological characterization of RP 62203, a novel 5-hydroxytryptamine 5-HT2 receptor antagonist |
Q39093171 | Pharmacology and Toxicology of N-Benzylphenethylamine ("NBOMe") Hallucinogens |
Q74097654 | Potentiation of DOI-induced forward locomotion in rats by (-)-pindolol pretreatment |
Q34167036 | Radioligand binding evidence implicates the brain 5-HT2 receptor as a site of action for LSD and phenylisopropylamine hallucinogens |
Q27027381 | Recent advances in the neuropsychopharmacology of serotonergic hallucinogens |
Q48787465 | Release of endogenous aspartate from rat cerebellum slices and synaptosomes: inhibition mediated by a 5-HT2 receptor and by a 5-HT1 receptor of a possibly novel subtype |
Q37602790 | Role of the 5-HT₂A receptor in the locomotor hyperactivity produced by phenylalkylamine hallucinogens in mice |
Q33178556 | Selectivity of action of typical and atypical anti-psychotic drugs as antagonists of the behavioral effects of 1-[2,5-dimethoxy-4-iodophenyl]-2-aminopropane (DOI). |
Q52054019 | Serotonergic modulation of the rat pup ultrasonic isolation call: studies with 5HT1 and 5HT2 subtype-selective agonists and antagonists |
Q48636711 | Serotonin 5-HT1A and 5-HT2/1C receptors in the midbrain periaqueductal gray differentially modulate defensive rage behavior elicited from the medial hypothalamus of the cat. |
Q38004450 | Serotonin receptor subtypes and sexual behavior |
Q47899794 | Serotonin suppresses subthreshold and suprathreshold oscillatory activity of rat inferior olivary neurones in vitro |
Q43570514 | Serotonin2 agonist administration down-regulates rat brain serotonin2 receptors |
Q28289039 | Structure-activity relationships of phenylalkylamines as agonist ligands for 5-HT(2A) receptors |
Q48389932 | The tricyclic antidepressant clomipramine dose-dependently reduces regional cerebral metabolic rates for glucose in awake rats |
Q51112892 | Use of the harmonic mean to the determination of dissociation constants of stereoisomeric mixtures of biologically active compounds. |
Q52252661 | Variability in the effects of 4-bromo-2,5-dimethoxyamphetamine (DOB) on operant behavior of squirrel monkeys |
Search more.